TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9262499
log Bayes Factor = 67.2392
Chromosome 6   position 30,987,098  (GRCh37) Explore rs9262499 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
1.000 0.000 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.000 1.000
L40 Psoriasis
1.000 0.000 0.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.000 1.000
L40.5 Arthropathic psoriasis
0.999 0.001 0.000
E00-E07 Disorders of thyroid gland
0.000 0.001 0.999
E03 Other hypothyroidism
0.000 0.005 0.995
E03.9 Hypothyroidism, unspecified
0.000 0.007 0.993
E05.9 Thyrotoxicosis, unspecified
0.000 0.008 0.992
L40.0 Psoriasis vulgaris
0.979 0.021 0.000
G35 Multiple sclerosis
0.000 0.058 0.942
E06 Thyroiditis
0.000 0.066 0.934
K90 Intestinal malabsorption
0.000 0.121 0.879
E06.3 Autoimmune thyroiditis
0.000 0.149 0.851
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.172 0.828
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.194 0.806
E06.9 Thyroiditis, unspecified
0.000 0.198 0.802
L40.1 Generalised pustular psoriasis
0.763 0.237 0.000
E53.8 Deficiency of other specified B group vitamins
0.000 0.238 0.762
E53 Deficiency of other B group vitamins
0.000 0.242 0.758
E50-E64 Other nutritional deficiencies
0.000 0.253 0.747
E03.8 Other specified hypothyroidism
0.000 0.257 0.743
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.257 0.743
L40.2 Acrodermatitis continua
0.717 0.283 0.000
E05.5 Thyroid crisis or storm
0.000 0.283 0.717
E05.4 Thyrotoxicosis factitia
0.000 0.283 0.717
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.283 0.717
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.283 0.717
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.284 0.716
E00 Congenital iodine-deficiency syndrome
0.000 0.284 0.716
E03.5 Myxoedema coma
0.000 0.287 0.713
E03.4 Atrophy of thyroid (acquired)
0.000 0.287 0.713
E03.3 Postinfectious hypothyroidism
0.000 0.287 0.713
L40.4 Guttate psoriasis
0.711 0.289 0.000
L40.8 Other psoriasis
0.702 0.298 0.000
K90.8 Other intestinal malabsorption
0.000 0.299 0.701
K90.9 Intestinal malabsorption, unspecified
0.000 0.300 0.700
G35-G37 Demyelinating diseases of the central nervous system
0.000 0.319 0.681
E06.5 Other chronic thyroiditis
0.000 0.329 0.671
E53.9 Vitamin B deficiency, unspecified
0.000 0.330 0.670
E06.4 Drug-induced thyroiditis
0.000 0.330 0.669
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.330 0.669
E06.0 Acute thyroiditis
0.000 0.330 0.669
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.339 0.661
L40.3 Pustulosis palmaris et plantaris
0.658 0.341 0.000
E03.1 Congenital hypothyroidism without goitre
0.000 0.341 0.658
E06.1 Subacute thyroiditis
0.000 0.365 0.635
E07 Other disorders of thyroid
0.000 0.367 0.633
E04 Other non-toxic goitre
0.000 0.368 0.632
K90.3 Pancreatic steatorrhoea
0.000 0.370 0.630
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.370 0.630
K90.1 Tropical sprue
0.000 0.370 0.630
G37 Other demyelinating diseases of central nervous system
0.000 0.372 0.628
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.421 0.579
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.426 0.574
E58 Dietary calcium deficiency
0.000 0.429 0.571
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.000 0.441 0.559
E51 Thiamine deficiency
0.000 0.442 0.558
E05.8 Other thyrotoxicosis
0.000 0.444 0.555
E04.0 Non-toxic diffuse goitre
0.000 0.455 0.545
E53.1 Pyridoxine deficiency
0.000 0.457 0.543
E53.0 Riboflavin deficiency
0.000 0.457 0.543
E56 Other vitamin deficiencies
0.000 0.463 0.536
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.464 0.536
E63 Other nutritional deficiencies
0.000 0.464 0.536
E50 Vitamin A deficiency
0.000 0.464 0.536
E60 Dietary zinc deficiency
0.000 0.464 0.536
E59 Dietary selenium deficiency
0.000 0.464 0.536
E52 Niacin deficiency [pellagra]
0.000 0.464 0.536
G37.8 Other specified demyelinating diseases of central nervous system
0.000 0.468 0.532
E61 Deficiency of other nutrient elements
0.000 0.476 0.524
E04.2 Non-toxic multinodular goitre
0.000 0.481 0.519
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.487 0.513
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.487 0.513
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.487 0.513
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.487 0.513
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.487 0.513
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.487 0.513
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.487 0.513
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.487 0.513
E54 Ascorbic acid deficiency
0.000 0.487 0.513
E40-E46 Malnutrition
0.000 0.489 0.511
G36 Other acute disseminated demyelination
0.000 0.512 0.488
E07.8 Other specified disorders of thyroid
0.000 0.526 0.474
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.538 0.462
E55 Vitamin D deficiency
0.000 0.543 0.457
E07.1 Dyshormogenetic goitre
0.000 0.546 0.454
E07.0 Hypersecretion of calcitonin
0.000 0.546 0.454
E04.8 Other specified non-toxic goitre
0.000 0.547 0.453
G37.5 Concentric sclerosis [Balo]
0.000 0.549 0.450
G37.4 Subacute necrotising myelitis
0.000 0.549 0.450
G37.2 Central pontine myelinolysis
0.000 0.549 0.450
G37.1 Central demyelination of corpus callosum
0.000 0.549 0.450
G37.0 Diffuse sclerosis
0.000 0.549 0.450
G37.9 Demyelinating disease of central nervous system, unspecified
0.000 0.550 0.450
E51.2 Wernicke's encephalopathy
0.000 0.578 0.422
L40-L45 Papulosquamous disorders
0.417 0.583 0.000
E51.9 Thiamine deficiency, unspecified
0.000 0.600 0.400
E51.8 Other manifestations of thiamine deficiency
0.000 0.600 0.400
E51.1 Beriberi
0.000 0.600 0.400
E56.1 Deficiency of vitamin K
0.000 0.615 0.385
E56.9 Vitamin deficiency, unspecified
0.000 0.615 0.385
E56.8 Deficiency of other vitamins
0.000 0.615 0.385
E56.0 Deficiency of vitamin E
0.000 0.615 0.385
E50.9 Vitamin A deficiency, unspecified
0.000 0.616 0.384
E50.8 Other manifestations of vitamin A deficiency
0.000 0.616 0.384
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.616 0.384
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.616 0.384
E50.5 Vitamin A deficiency with night blindness
0.000 0.616 0.384
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.616 0.384
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.616 0.384
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.616 0.384
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.616 0.384
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.616 0.384
E63.9 Nutritional deficiency, unspecified
0.000 0.616 0.384
E63.8 Other specified nutritional deficiencies
0.000 0.616 0.384
E63.1 Imbalance of constituents of food intake
0.000 0.616 0.384
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.616 0.384
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.616 0.384
E64.8 Sequelae of other nutritional deficiencies
0.000 0.616 0.384
E64.3 Sequelae of rickets
0.000 0.616 0.384
E64.2 Sequelae of vitamin C deficiency
0.000 0.616 0.384
E64.1 Sequelae of vitamin A deficiency
0.000 0.616 0.384
E64.0 Sequelae of protein-energy malnutrition
0.000 0.616 0.384
E61.1 Iron deficiency
0.000 0.616 0.384
E61.9 Deficiency of nutrient element, unspecified
0.000 0.624 0.376
E61.8 Deficiency of other specified nutrient elements
0.000 0.624 0.376
E61.7 Deficiency of multiple nutrient elements
0.000 0.624 0.376
E61.6 Vanadium deficiency
0.000 0.624 0.376
E61.5 Molybdenum deficiency
0.000 0.624 0.376
E61.4 Chromium deficiency
0.000 0.624 0.376
E61.3 Manganese deficiency
0.000 0.624 0.376
E61.0 Copper deficiency
0.000 0.624 0.376
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.633 0.367
E45 Retarded development following protein-energy malnutrition
0.000 0.633 0.367
E43 Unspecified severe protein-energy malnutrition
0.000 0.633 0.367
E42 Marasmic kwashiorkor
0.000 0.633 0.367
E41 Nutritional marasmus
0.000 0.633 0.367
E40 Kwashiorkor
0.000 0.633 0.367
E04.9 Non-toxic goitre, unspecified
0.000 0.636 0.363
E61.2 Magnesium deficiency
0.000 0.646 0.354
G36.9 Acute disseminated demyelination, unspecified
0.000 0.650 0.350
G36.8 Other specified acute disseminated demyelination
0.000 0.650 0.350
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.000 0.650 0.350
G36.0 Neuromyelitis optica [Devic]
0.000 0.650 0.350
E46 Unspecified protein-energy malnutrition
0.000 0.655 0.345
E07.9 Disorder of thyroid, unspecified
0.000 0.661 0.339
E65-E68 Obesity and other hyperalimentation
0.000 0.664 0.336
E15 Nondiabetic hypoglycaemic coma
0.000 0.669 0.331
E55.0 Rickets, active
0.000 0.672 0.328
L42 Pityriasis rosea
0.311 0.689 0.000
L44 Other papulosquamous disorders
0.309 0.691 0.000
E70-E90 Metabolic disorders
0.000 0.699 0.301
E89.0 Postprocedural hypothyroidism
0.000 0.700 0.300
L41 Parapsoriasis
0.299 0.701 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.299 0.701 0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.704 0.296
E10-E14 Diabetes mellitus
0.000 0.724 0.276
E83.1 Disorders of iron metabolism
0.000 0.727 0.273
L43 Lichen planus
0.272 0.728 0.000
E83 Disorders of mineral metabolism
0.000 0.731 0.269
E44.1 Mild protein-energy malnutrition
0.000 0.737 0.263
E44.0 Moderate protein-energy malnutrition
0.000 0.737 0.263
E16 Other disorders of pancreatic internal secretion
0.000 0.739 0.261
E55.9 Vitamin D deficiency, unspecified
0.000 0.751 0.249
E67 Other hyperalimentation
0.000 0.759 0.241
E68 Sequelae of hyperalimentation
0.000 0.759 0.241
E20-E35 Disorders of other endocrine glands
0.000 0.761 0.239
E10 Insulin-dependent diabetes mellitus
0.000 0.764 0.236
E10.9 Without complications
0.000 0.765 0.235
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.767 0.233
L44.0 Pityriasis rubra pilaris
0.232 0.768 0.000
E65 Localised adiposity
0.000 0.768 0.232
E27.1 Primary adrenocortical insufficiency
0.000 0.777 0.223
L44.9 Papulosquamous disorder, unspecified
0.222 0.778 0.000
L44.8 Other specified papulosquamous disorders
0.222 0.778 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.222 0.778 0.000
L44.3 Lichen ruber moniliformis
0.222 0.778 0.000
L44.2 Lichen striatus
0.222 0.778 0.000
L44.1 Lichen nitidus
0.222 0.778 0.000
E27 Other disorders of adrenal gland
0.000 0.779 0.221
E84 Cystic fibrosis
0.000 0.781 0.219
E77 Disorders of glycoprotein metabolism
0.000 0.784 0.216
E76 Disorders of glycosaminoglycan metabolism
0.000 0.784 0.216
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.784 0.216
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.784 0.216
L41.9 Parapsoriasis, unspecified
0.214 0.785 0.000
L41.8 Other parapsoriasis
0.214 0.785 0.000
L41.5 Retiform parapsoriasis
0.214 0.785 0.000
L41.4 Large plaque parapsoriasis
0.214 0.785 0.000
L41.3 Small plaque parapsoriasis
0.214 0.785 0.000
L41.2 Lymphomatoid papulosis
0.214 0.785 0.000
L41.1 Pityriasis lichenoides chronica
0.214 0.785 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.214 0.785 0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.786 0.214
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.786 0.214
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.788 0.212
E89.1 Postprocedural hypoinsulinaemia
0.000 0.788 0.212
R31 Unspecified haematuria
0.209 0.791 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.791 0.209
E79 Disorders of purine and pyrimidine metabolism
0.000 0.791 0.209
E70 Disorders of aromatic amino-acid metabolism
0.000 0.793 0.207
E88 Other metabolic disorders
0.000 0.797 0.203
E85 Amyloidosis
0.000 0.798 0.202
E10.3 With ophthalmic complications
0.000 0.799 0.201
E12 Malnutrition-related diabetes mellitus
0.000 0.802 0.198
L43.8 Other lichen planus
0.196 0.804 0.000
E89.4 Postprocedural ovarian failure
0.000 0.804 0.196
L43.3 Subacute (active) lichen planus
0.195 0.805 0.000
L43.2 Lichenoid drug reaction
0.195 0.805 0.000
L43.1 Bullous lichen planus
0.195 0.805 0.000
L43.0 Hypertrophic lichen planus
0.195 0.805 0.000
E73 Lactose intolerance
0.000 0.805 0.195
E80.4 Gilbert's syndrome
0.000 0.806 0.194
E72 Other disorders of amino-acid metabolism
0.000 0.806 0.194
E83.9 Disorder of mineral metabolism, unspecified
0.000 0.807 0.193
E83.8 Other disorders of mineral metabolism
0.000 0.807 0.193
E83.2 Disorders of zinc metabolism
0.000 0.807 0.193
E83.0 Disorders of copper metabolism
0.000 0.807 0.193
E89.2 Postprocedural hypoparathyroidism
0.000 0.810 0.190
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.810 0.189
E29 Testicular dysfunction
0.000 0.811 0.189
E74 Other disorders of carbohydrate metabolism
0.000 0.813 0.187
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.813 0.187
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.813 0.187
E16.4 Abnormal secretion of gastrin
0.000 0.813 0.187
E16.3 Increased secretion of glucagon
0.000 0.813 0.187
E22 Hyperfunction of pituitary gland
0.000 0.816 0.184
E10.2 With renal complications
0.000 0.816 0.184
E20 Hypoparathyroidism
0.000 0.819 0.181
E89.5 Postprocedural testicular hypofunction
0.000 0.819 0.180
E80.1 Porphyria cutanea tarda
0.000 0.821 0.179
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.825 0.175
E31 Polyglandular dysfunction
0.000 0.825 0.175
E89.3 Postprocedural hypopituitarism
0.000 0.826 0.174
E67.8 Other specified hyperalimentation
0.000 0.827 0.173
E67.3 Hypervitaminosis D
0.000 0.827 0.173
E67.2 Megavitamin-B6 syndrome
0.000 0.827 0.173
E67.1 Hypercarotenaemia
0.000 0.827 0.173
E67.0 Hypervitaminosis A
0.000 0.827 0.173
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.829 0.171
E32 Diseases of thymus
0.000 0.829 0.171
E30 Disorders of puberty, not elsewhere classified
0.000 0.829 0.171
E80.6 Other disorders of bilirubin metabolism
0.000 0.832 0.168
L43.9 Lichen planus, unspecified
0.167 0.833 0.000
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.833 0.167
E80.5 Crigler-Najjar syndrome
0.000 0.833 0.167
E80.3 Defects of catalase and peroxydase
0.000 0.833 0.167
E80.0 Hereditary erythropoietic porphyria
0.000 0.833 0.167
E22.1 Hyperprolactinaemia
0.000 0.834 0.166
E10.5 With peripheral circulatory complications
0.000 0.837 0.163
E84.9 Cystic fibrosis, unspecified
0.000 0.840 0.160
E13 Other specified diabetes mellitus
0.000 0.840 0.160
E27.5 Adrenomedullary hyperfunction
0.000 0.841 0.159
E27.0 Other adrenocortical overactivity
0.000 0.841 0.159
E84.8 Cystic fibrosis with other manifestations
0.000 0.843 0.157
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.843 0.157
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.843 0.157
E71.3 Disorders of fatty-acid metabolism
0.000 0.845 0.155
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.845 0.155
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.845 0.155
E71.0 Maple-syrup-urine disease
0.000 0.845 0.155
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.845 0.155
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.845 0.155
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.845 0.155
E76.2 Other mucopolysaccharidoses
0.000 0.845 0.155
E76.1 Mucopolysaccharidosis, type II
0.000 0.845 0.155
E76.0 Mucopolysaccharidosis, type I
0.000 0.845 0.155
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.845 0.155
E77.8 Other disorders of glycoprotein metabolism
0.000 0.845 0.155
E77.1 Defects in glycoprotein degradation
0.000 0.845 0.155
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.845 0.155
E85.4 Organ-limited amyloidosis
0.000 0.846 0.154
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.847 0.153
E29.1 Testicular hypofunction
0.000 0.847 0.153
E25 Adrenogenital disorders
0.000 0.848 0.152
E26 Hyperaldosteronism
0.000 0.848 0.152
E10.7 With multiple complications
0.000 0.848 0.151
E20.9 Hypoparathyroidism, unspecified
0.000 0.849 0.150
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.850 0.150
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.850 0.150
E79.1 Lesch-Nyhan syndrome
0.000 0.850 0.150
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.850 0.150
E88.3 Tumour lysis syndrome
0.000 0.850 0.149
E14 Unspecified diabetes mellitus
0.000 0.850 0.150
E85.8 Other amyloidosis
0.000 0.851 0.149
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.851 0.148
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.851 0.148
E70.2 Disorders of tyrosine metabolism
0.000 0.851 0.148
E70.1 Other hyperphenylalaninaemias
0.000 0.851 0.148
E70.0 Classical phenylketonuria
0.000 0.851 0.148
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.855 0.145
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.855 0.145
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.855 0.145
E16.1 Other hypoglycaemia
0.000 0.856 0.144
E27.2 Addisonian crisis
0.000 0.857 0.143
E12.9 Without complications
0.000 0.858 0.142
E12.8 With unspecified complications
0.000 0.858 0.142
E12.7 With multiple complications
0.000 0.858 0.142
E12.6 With other specified complications
0.000 0.858 0.142
E12.5 With peripheral circulatory complications
0.000 0.858 0.142
E12.4 With neurological complications
0.000 0.858 0.142
E12.3 With ophthalmic complications
0.000 0.858 0.142
E12.2 With renal complications
0.000 0.858 0.142
E12.1 With ketoacidosis
0.000 0.858 0.142
E12.0 With coma
0.000 0.858 0.142
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.858 0.142
E14.3 With ophthalmic complications
0.000 0.858 0.142
E73.8 Other lactose intolerance
0.000 0.860 0.140
E73.1 Secondary lactase deficiency
0.000 0.860 0.140
E73.0 Congenital lactase deficiency
0.000 0.860 0.140
E28 Ovarian dysfunction
0.000 0.860 0.140
E88.9 Metabolic disorder, unspecified
0.000 0.860 0.139
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.860 0.139
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.860 0.139
E72.5 Disorders of glycine metabolism
0.000 0.860 0.139
E72.4 Disorders of ornithine metabolism
0.000 0.860 0.139
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.860 0.139
E72.2 Disorders of urea cycle metabolism
0.000 0.860 0.139
E22.0 Acromegaly and pituitary gigantism
0.000 0.861 0.139
E70.3 Albinism
0.000 0.861 0.139
E75.6 Lipid storage disorder, unspecified
0.000 0.864 0.136
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.864 0.136
E75.3 Sphingolipidosis, unspecified
0.000 0.864 0.136
E75.1 Other gangliosidosis
0.000 0.864 0.136
E75.0 GM2 gangliosidosis
0.000 0.864 0.136
E29.9 Testicular dysfunction, unspecified
0.000 0.864 0.135
E29.8 Other testicular dysfunction
0.000 0.864 0.135
E29.0 Testicular hyperfunction
0.000 0.864 0.135
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.865 0.134
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.865 0.134
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.865 0.134
E74.2 Disorders of galactose metabolism
0.000 0.865 0.134
E74.1 Disorders of fructose metabolism
0.000 0.865 0.134
E74.0 Glycogen storage disease
0.000 0.865 0.134
E10.8 With unspecified complications
0.000 0.866 0.134
E34 Other endocrine disorders
0.000 0.866 0.134
E72.0 Disorders of amino-acid transport
0.000 0.866 0.134
E85.3 Secondary systemic amyloidosis
0.000 0.867 0.133
E83.3 Disorders of phosphorus metabolism
0.000 0.867 0.133
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.868 0.132
E22.8 Other hyperfunction of pituitary gland
0.000 0.868 0.132
E88.8 Other specified metabolic disorders
0.000 0.868 0.132
E10.1 With ketoacidosis
0.000 0.868 0.132
E80.2 Other porphyria
0.000 0.868 0.132
E16.2 Hypoglycaemia, unspecified
0.000 0.868 0.132
E10.6 With other specified complications
0.000 0.870 0.130
E20.8 Other hypoparathyroidism
0.000 0.870 0.130
E20.0 Idiopathic hypoparathyroidism
0.000 0.870 0.130
E31.0 Autoimmune polyglandular failure
0.000 0.871 0.129
E75.5 Other lipid storage disorders
0.000 0.871 0.128
E85.9 Amyloidosis, unspecified
0.000 0.872 0.127
E88.2 Lipomatosis, not elsewhere classified
0.000 0.873 0.127
E31.9 Polyglandular dysfunction, unspecified
0.000 0.874 0.125
E31.8 Other polyglandular dysfunction
0.000 0.874 0.125
E31.1 Polyglandular hyperfunction
0.000 0.874 0.125
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.875 0.124
E30.9 Disorder of puberty, unspecified
0.000 0.877 0.123
E30.8 Other disorders of puberty
0.000 0.877 0.123
E30.1 Precocious puberty
0.000 0.877 0.123
E30.0 Delayed puberty
0.000 0.877 0.123
E32.9 Disease of thymus, unspecified
0.000 0.877 0.123
E32.8 Other diseases of thymus
0.000 0.877 0.123
E32.1 Abscess of thymus
0.000 0.877 0.123
E32.0 Persistent hyperplasia of thymus
0.000 0.877 0.123
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.877 0.123
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.877 0.123
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.877 0.123
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.878 0.122
E75.2 Other sphingolipidosis
0.000 0.881 0.119
E73.9 Lactose intolerance, unspecified
0.000 0.881 0.119
E10.4 With neurological complications
0.000 0.885 0.115
E28.3 Primary ovarian failure
0.000 0.885 0.115
E13.8 With unspecified complications
0.000 0.885 0.115
E13.7 With multiple complications
0.000 0.885 0.115
E13.6 With other specified complications
0.000 0.885 0.115
E13.5 With peripheral circulatory complications
0.000 0.885 0.115
E13.4 With neurological complications
0.000 0.885 0.115
E13.3 With ophthalmic complications
0.000 0.885 0.115
E13.2 With renal complications
0.000 0.885 0.115
E13.1 With ketoacidosis
0.000 0.885 0.115
E13.0 With coma
0.000 0.885 0.115
E27.9 Disorder of adrenal gland, unspecified
0.000 0.885 0.114
E20.1 Pseudohypoparathyroidism
0.000 0.888 0.111
E10.0 With coma
0.000 0.889 0.110
E14.6 With other specified complications
0.000 0.890 0.110
E25.9 Adrenogenital disorder, unspecified
0.000 0.891 0.109
E25.8 Other adrenogenital disorders
0.000 0.891 0.109
E26.9 Hyperaldosteronism, unspecified
0.000 0.891 0.109
E26.8 Other hyperaldosteronism
0.000 0.891 0.109
E26.1 Secondary hyperaldosteronism
0.000 0.891 0.109
E14.8 With unspecified complications
0.000 0.892 0.108
E14.7 With multiple complications
0.000 0.892 0.107
E14.0 With coma
0.000 0.892 0.107
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.894 0.105
E24 Cushing's syndrome
0.001 0.897 0.103
E14.5 With peripheral circulatory complications
0.000 0.897 0.103
E34.0 Carcinoid syndrome
0.000 0.897 0.103
E28.9 Ovarian dysfunction, unspecified
0.000 0.899 0.100
E28.8 Other ovarian dysfunction
0.000 0.899 0.100
E28.1 Androgen excess
0.000 0.899 0.100
E28.0 Oestrogen excess
0.000 0.899 0.100
E23 Hypofunction and other disorders of pituitary gland
0.000 0.900 0.100
E34.5 Androgen resistance syndrome
0.000 0.904 0.096
E34.4 Constitutional tall stature
0.000 0.904 0.096
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.904 0.096
E34.1 Other hypersecretion of intestinal hormones
0.000 0.904 0.096
E34.3 Short stature, not elsewhere classified
0.000 0.904 0.096
E14.2 Withrenal complications
0.000 0.909 0.091
E14.1 With ketoacidosis
0.000 0.909 0.091
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.910 0.089
E26.0 Primary hyperaldosteronism
0.000 0.910 0.089
E27.8 Other specified disorders of adrenal gland
0.000 0.915 0.084
E14.4 With neurological complications
0.000 0.920 0.080
E34.8 Other specified endocrine disorders
0.000 0.922 0.078
E13.9 Without complications
0.000 0.924 0.076
E83.5 Disorders of calcium metabolism
0.000 0.924 0.076
E24.0 Pituitary-dependent Cushing's disease
0.001 0.924 0.075
E23.7 Disorder of pituitary gland, unspecified
0.000 0.925 0.075
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.001 0.926 0.074
E24.3 Ectopic ACTH syndrome
0.001 0.926 0.074
E24.1 Nelson's syndrome
0.001 0.926 0.074
E83.4 Disorders of magnesium metabolism
0.000 0.927 0.073
E34.9 Endocrine disorder, unspecified
0.000 0.927 0.072
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.928 0.072
E23.1 Drug-induced hypopituitarism
0.000 0.928 0.072
E24.2 Drug-induced Cushing's syndrome
0.001 0.929 0.070
M35.0 Sicca syndrome [Sjogren]
0.000 0.929 0.071
E04.1 Non-toxic single thyroid nodule
0.001 0.930 0.069
E66 Obesity
0.000 0.931 0.069
E24.8 Other Cushing's syndrome
0.001 0.931 0.068
K90-K93 Other diseases of the digestive system
0.000 0.934 0.066
E23.2 Diabetes insipidus
0.000 0.936 0.064
E23.6 Other disorders of pituitary gland
0.000 0.937 0.063
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.940 0.060
E86 Volume depletion
0.000 0.941 0.059
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.943 0.057
F41.9 Anxiety disorder, unspecified
0.055 0.945 0.000
F41 Other anxiety disorders
0.050 0.950 0.000
E66.1 Drug-induced obesity
0.000 0.950 0.050
F41.0 Panic disorder [episodic paroxysmal anxiety]
0.050 0.950 0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.950 0.050
F41.2 Mixed anxiety and depressive disorder
0.049 0.951 0.000
E66.8 Other obesity
0.000 0.952 0.048
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.952 0.048
E21.2 Other hyperparathyroidism
0.000 0.955 0.045
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.957 0.043
J47 Bronchiectasis
0.000 0.958 0.042
E21.4 Other specified disorders of parathyroid gland
0.000 0.959 0.041
M35 Other systemic involvement of connective tissue
0.000 0.963 0.037
F41.8 Other specified anxiety disorders
0.035 0.965 0.000
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.000 0.965 0.034
K93.1 Megacolon in Chagas' disease
0.000 0.965 0.034
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.000 0.965 0.034
E66.0 Obesity due to excess calories
0.000 0.967 0.032
E23.0 Hypopituitarism
0.000 0.968 0.032
M35.7 Hypermobility syndrome
0.000 0.969 0.031
E28.2 Polycystic ovarian syndrome
0.001 0.971 0.028
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.971 0.029
F41.3 Other mixed anxiety disorders
0.028 0.971 0.000
M35.1 Other overlap syndromes
0.000 0.971 0.029
E24.9 Cushing's syndrome, unspecified
0.002 0.971 0.027
D23.1 Skin of eyelid, including canthus
0.000 0.972 0.028
M35.2 Behcet's disease
0.000 0.973 0.027
M35.9 Systemic involvement of connective tissue, unspecified
0.000 0.973 0.027
M35.6 Relapsing panniculitis [Weber-Christian]
0.000 0.973 0.027
M35.5 Multifocal fibrosclerosis
0.000 0.973 0.027
M35.4 Diffuse (eosinophilic) fasciitis
0.000 0.973 0.027
M35.8 Other specified systemic involvement of connective tissue
0.000 0.974 0.025
M35.3 Polymyalgia rheumatica
0.000 0.975 0.025
R30-R39 Symptoms and signs involving the urinary system
0.023 0.977 0.000
R30 Pain associated with micturition
0.022 0.978 0.000
R30.0 Dysuria
0.021 0.979 0.000
C32.0 Glottis
0.021 0.979 0.000
M35.99 Systemic involvement of connective tissue, unspecified, Site unspecified
0.000 0.980 0.019
R34 Anuria and oliguria
0.020 0.980 0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified
0.000 0.981 0.019
R30.1 Vesical tenesmus
0.018 0.982 0.000
Q61 Cystic kidney disease
0.017 0.983 0.000
Q61.3 Polycystic kidney, unspecified
0.017 0.983 0.000
Q61.2 Polycystic kidney, adult type
0.016 0.984 0.000
Q61.0 Congenital single renal cyst
0.016 0.984 0.000
R39 Other symptoms and signs involving the urinary system
0.016 0.984 0.000
E21.0 Primary hyperparathyroidism
0.000 0.984 0.016
K91.9 Postprocedural disorder of digestive system, unspecified
0.000 0.985 0.015
K91.0 Vomiting following gastro-intestinal surgery
0.000 0.986 0.014
R39.8 Other and unspecified symptoms and signs involving the urinary system
0.014 0.986 0.000
E21.3 Hyperparathyroidism, unspecified
0.000 0.986 0.014
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified
0.000 0.986 0.014
K91.2 Postsurgical malabsorption, not elsewhere classified
0.000 0.987 0.013
R36 Urethral discharge
0.013 0.987 0.000
R39.0 Extravasation of urine
0.013 0.987 0.000
F41.1 Generalised anxiety disorder
0.013 0.987 0.000
Q61.4 Renal dysplasia
0.013 0.987 0.000
E87 Other disorders of fluid, electrolyte and acid-base balance
0.000 0.987 0.013
Q61.9 Cystic kidney disease, unspecified
0.013 0.987 0.000
R35 Polyuria
0.013 0.987 0.000
Q61.8 Other cystic kidney diseases
0.012 0.988 0.000
Q61.1 Polycystic kidney, infantile type
0.012 0.988 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.